Amneal Announces Dihydroergotamine (DHE) Autoinjector NDA for Migraines and Cluster Headaches
Amneal announced that the FDA accepted Amneal’s 505(b)(2) NDA for a newly licensed dihydroergotamine (DHE) prefilled ...
Read more
Tag: Amneal
Amneal Reports Net Revenue of $493 million in Q1 2021
Q1 2021 Net Revenue of $493 million; GAAP Net Income of $7 million; Diluted Income per ...
Read moreAmneal Completes Acquisition of Kashiv Specialty Pharmaceuticals
Amneal Pharmaceuticals, Inc. and Kashiv BioSciences LLC today announced that Amneal Pharmaceuticals LLC , a subsidiary ...
Read more